Actualizado el 29 de octubre de 2026
AI Platform for Statistical Analysis of Clinical, Cosmetic and Medical Device Studies
CEO en Synthetrial S.L.
Acerca de
Synthetrial’s platform uses artificial intelligence to automate and accelerate the statistical analysis of pharmaceutical clinical trials, cosmetic studies and medical device investigations.
Using the study protocol, Statistical Analysis Plan (SAP) and study database, the platform interprets the analysis requirements, performs the corresponding calculations and generates structured results, tables and visualizations within hours.
The platform enables organizations to:
-
Automate repetitive statistical analyses.
-
Reduce manual errors and improve traceability.
-
Assess efficacy, safety, tolerability and performance endpoints.
-
Explore patient, user or participant subgroups.
-
Identify responder profiles and relevant patterns.
-
Compare endpoints and alternative scenarios.
-
Generate tables, results and visualizations rapidly.
-
Accelerate the preparation of statistical and study reports.
-
Free scientific and statistical teams from repetitive operational tasks.
The solution transforms processes that traditionally require days or weeks into significantly faster workflows while keeping qualified professionals in control of the analysis and its interpretation.
It is designed for pharmaceutical and biotechnology companies, cosmetics manufacturers, medical device companies, CROs and testing laboratories seeking to accelerate analysis, optimize resources and improve decision-making throughout product development.
Oportunidades similares
Producto
AI Platform for Clinical, Cosmetic and Medical Device Study Protocol Design
José Ignacio Klett
CEO en Synthetrial S.L.
Producto
Synthetic Data for Pharmaceutical, Cosmetic and Medical Device Studies
José Ignacio Klett
CEO en Synthetrial S.L.
Servicio
- Other
- Consulting
- Testing & Analysis
- Innovation management
- Research & Development
Javier Fernández
CEO & CPO en Seguritur Solutions S.L.